Health Care & Life Sciences » Pharmaceuticals | Yantai Dongcheng Biochemicals Co. Ltd.

Yantai Dongcheng Biochemicals Co. Ltd. | Mutual Funds

Mutual Funds that own Yantai Dongcheng Biochemicals Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
2,498,846
0.43%
0
2.24%
12/31/2017
Hong Yang Fund
2,244,303
0.39%
2,244,303
1.1%
12/31/2016
Zhonghai Advantage Growth Fund
2,025,125
0.35%
2,025,125
1.22%
12/31/2017
1,900,000
0.33%
-344,303
5.75%
12/31/2017
1,700,000
0.28%
-89,950
5.16%
12/31/2017
1,654,700
0.28%
1,610,200
0.57%
12/31/2017
LC Value Discovery Equity Fund
1,532,190
0.27%
1,532,190
0.25%
12/31/2017
1,282,847
0.22%
-3,016,970
1.6%
12/31/2017
1,262,100
0.22%
94,500
0.78%
12/31/2017
1,242,900
0.22%
1,242,900
0.4%
12/31/2017

About Yantai Dongcheng Biochemicals Co.

View Profile
Address
No. 7 Changbaishan Road
Yantai Shandong 264006
China
Employees -
Website http://www.dcb-group.com
Updated 07/08/2019
Yantai Dongcheng Biochemicals Co., Ltd. engages in the research and development, production, and marketing of biochemical active pharmaceutical ingredient (API). It involves in API, chemical synthetic drugs, and modern chinese medicines. The firm's products include heparin series, chondroitin sulphate, marine collagen, hyaluronic acid, glucosamine series, heparinoid, and cytochrome C.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.